The role of screening, brief intervention, and referral to treatment in the perinatal period
- PMID: 27373599
- PMCID: PMC11362984
- DOI: 10.1016/j.ajog.2016.06.038
The role of screening, brief intervention, and referral to treatment in the perinatal period
Abstract
Substance use during pregnancy is at least as common as many of the medical conditions screened for and managed during pregnancy. While harmful and costly, it is often ignored or managed poorly. Screening, brief intervention, and referral to treatment is an evidence-based approach to manage substance use. In September 2012, the US Centers for Disease Control and Prevention convened an Expert Meeting on Perinatal Illicit Drug Abuse to help address key issues around drug use in pregnancy in the United States. This article reflects the formal conclusions of the expert panel that discussed the use of screening, brief intervention, and referral to treatment during pregnancy. Screening for substance use during pregnancy should be universal. It allows stratification of women into zones of risk given their pattern of use. Low-risk women should receive brief advice, those classified as moderate risk should receive a brief intervention, whereas those who are high risk need referral to specialty care. A brief intervention is a patient-centered form of counseling using the principles of motivational interviewing. Screening, brief intervention, and referral to treatment has the potential to reduce the burden of substance use in pregnancy and should be integrated into prenatal care.
Keywords: alcohol; brief intervention; opioid use; pregnancy; referral to treatment; screening; substance use disorders; tobacco.
Copyright © 2016 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no conflict of interest.
Figures
Comment in
-
Screening, brief intervention, referral to treatment: time to get to work.Am J Obstet Gynecol. 2016 Nov;215(5):537-538. doi: 10.1016/j.ajog.2016.08.006. Am J Obstet Gynecol. 2016. PMID: 27793309 No abstract available.
References
-
- Substance Abuse and Mental Health Services Administration. Results from the 2013 national survey on drug use and health: summary of national findings, NSDUH series H-48, HHS publication no. (SMA) 14–4863. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2014.
-
- Viteri OA, Soto EE, Bahado-Singh RO, Christensen CW, Chauhan SP, Sibai BM. Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review. Am J Perinatol 2015;32:405–16. - PubMed
-
- Substance Abuse and Mental Health Services Administration. Prevention of substance abuse and mental illness. 2014. Available at: http://www.samhsa.gov/prevention. Accessed April 13, 2015.
-
- Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307:1934–40. - PubMed
-
- American College of Obstetricians and Gynecologists. At-risk drinking and illicit drug use: ethical issues in obstetric and gynecologic practice. ACOG Committee opinion no. 422. Obstet Gynecol 2008;112:1449–60. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical